Fibromiyalji Sendromunda Görülen Ağrı Tipleri

Borchers AT, Gershwin ME. Fibromyalgia: a critical and comprehensive review. Clin Rev Allergy Immunol. 2015;49:100–51.
Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F. Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol. 2020;16(11):645–60.
Lorena SB de, Pimentel EA dos S, Fernandes VM, Pedrosa MB, Ranzolin A, Duarte ALBP. Evaluation of pain and quality of life of fibromyalgia patients. Rev Dor. 2016;17:8–11.
Råheim M, Håland W. Lived experience of chronic pain and fibromyalgia: Women’s stories from daily life. Qual Health Res. 2006;16(6):741–61.
Kosek E, Cohen M, Baron R, Gebhart GF, Mico JA, Rice ASC, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382–6.
Freynhagen R, Arevalo Parada H, Alberto Calderon-Ospina C, Chen J, Rakhmawati Emril D, Fernández-Villacorta FJ, et al. Current understanding of the mixed pain concept: a brief narrative review. Taylor Fr. 2019 Jun;35(6):1011–8.
Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Häuser W, Katz RL, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. In: Seminars in arthritis and rheumatism. Elsevier; 2016. p. 319–29.
Ramírez M, Martínez-Martínez L-A, Hernández-Quintela E, Velazco-Casapía J, Vargas A, Martínez-Lavín M. Small fiber neuropathy in women with fibromyalgia. An in vivo assessment using corneal confocal bio-microscopy. In: Seminars in arthritis and rheumatism. Elsevier; 2015. p. 214–9.
Martínez-Lavín M. Fibromyalgia and small fiber neuropathy: the plot thickens! Clin Rheumatol. 2018;37(12):3167–71.
Caro XJ, Winter EF. The role and importance of small fiber neuropathy in fibromyalgia pain. Curr Pain Headache Rep. 2015;19:1–7.
Kosek E, Clauw D, Nijs J, Baron R, Gilron I, Harris RE, et al. Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain [Internet]. 2021 May; Available from: https://doi.org/10.1097/j.pain.0000000000002324
Fitzcharles M-A, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Häuser W. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021;397(10289):2098–110.
No Title [Internet]. p. https://www.iasp-pain.org/resources/terminology. Available from: https://www.iasp-pain.org/resources/terminology
Bidari A, Ghavidel-Parsa B, Ghalehbaghi B. Reliability of ACR criteria over time to differentiate classic fibromyalgia from nonspecific widespread pain syndrome: a 6-month prospective cohort study. Mod Rheumatol. 2009;19(6):663–9.
Häuser W, Ablin J, Fitzcharles M-A, Littlejohn G, Luciano J V, Usui C, et al. Fibromyalgia. Nat Rev Dis Prim. 2015;1(1):1–16.
Clauw D. Time to stop the fibromyalgia criteria wars and refocus on identifying and treating individuals with this type of pain earlier in their illness. 2021;
Yunus MB. Central Sensitivity Syndromes: A New Paradigm and Group Nosology for Fibromyalgia and Overlapping Conditions, and the Related Issue of Disease versus Illness. Semin Arthritis Rheum [Internet]. 2008;37(6):339–52. Available from: https://www.sciencedirect.com/science/article/pii/S0049017207001473
Ghavidel‐Parsa B, Bidari A, Atrkarroushan Z, Khosousi M. Implication of the nociplastic features for clinical diagnosis of fibromyalgia: development of the preliminary Nociplastic‐Based Fibromyalgia Features (NFF) tool. ACR open Rheumatol. 2022;4(3):260–8.
Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019;160(1):53.
Üçeyler N, Zeller D, Kahn A-K, Kewenig S, Kittel-Schneider S, Schmid A, et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain. 2013;136(6):1857–67.
Doppler K, Rittner HL, Deckart M, Sommer C. Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia. Pain. 2015;156(11):2319–25.
Haanpää M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D, et al. NeuPSIG guidelines on neuropathic pain assessment. Vol. 152, Pain. No longer published by Elsevier; 2011. p. 14–27.
Devigili G, Cazzato D, Lauria G. Clinical diagnosis and management of small fiber neuropathy: an update on best practice. Expert Rev Neurother [Internet]. 2020 Sep 1;20(9):967–80. Available from: https://doi.org/10.1080/14737175.2020.1794825
Úbeda-D’Ocasar E, Valera-Calero JA, Gallego-Sendarrubias GM, Fernandez-de-Las-Penas C, Arias-Buría JL, Morales-Cabezas M, et al. Association of neuropathic pain symptoms with sensitization related symptomatology in women with fibromyalgia. Biomedicines. 2022;10(3):612.
Kösehasanoğullari M, Gündüz NE, Akalin E. Is fibromyalgia syndrome a neuropathic pain syndrome? Arch Rheumatol. 2019;34(2):196.
Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005;6(3):149–58.
Freynhagen R, Baron R, Gockel U, Tölle TR. Pain DETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22(10):1911–20.
Gierthmühlen J, Schneider U, Seemann M, Freitag-Wolf S, Maihöfner C, Enax-Krumova EK, et al. Can self-reported pain characteristics and bedside test be used for the assessment of pain mechanisms? An analysis of results of neuropathic pain questionnaires and quantitative sensory testing. Pain [Internet]. 2019;160(9). Available from: https://journals.lww.com/pain/fulltext/2019/09000/can_self_reported_pain_characteristics_and_bedside.19.aspx
Attal N, Baron R, Bouhassira D, Drangholt M, Dyck PJ, Edwards RR, et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. PAIN®. 2013;154(9):1807–19.
Freynhagen R, Rey R, Argoff C. When to consider “mixed pain”? The right questions can make a difference! Curr Med Res Opin [Internet]. 2020 Dec 1;36(12):2037–46. Available from: https://doi.org/10.1080/03007995.2020.1832058
Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis [Internet]. 2017;76(2):318–28. Available from: https://ard.bmj.com/content/76/2/318
Kundakci B, Hall M, Atzeni F, Branco J, Buskila D, Clauw D, et al. International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia. In: Seminars in arthritis and rheumatism. Elsevier; 2022. p. 152101.
Perrot S, Choy E, Petersel D, Ginovker A, Kramer E. Survey of physician experiences and perceptions about the diagnosis and treatment of fibromyalgia. BMC Health Serv Res. 2012;12(1):1–8.
Briones-Vozmediano E, Vives-Cases C, Ronda-Pérez E, Gil-González D. Patients’ and professionals’ views on managing fibromyalgia. Pain Res Manag. 2013;18:19–24.
Häuser W, Sarzi-Puttini P, Fitzcharles M-A. Fibromyalgia syndrome: under-, over-and misdiagnosis. Clin Exp Rheumatol. 2019;37(Suppl 116):90–7.
Nijs J, Lahousse A, Kapreli E, Bilika P, Saraçoğlu İ, Malfliet A, et al. Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future. J Clin Med [Internet]. 2021;10(15). Available from: https://www.mdpi.com/2077-0383/10/15/3203
Torres JR, Martos IC, Sánchez IT, Rubio AO, Pelegrina AD, Valenza MC. Results of an active neurodynamic mobilization program in patients with fibromyalgia syndrome: a randomized controlled trial. Arch Phys Med Rehabil. 2015;96(10):1771–8.
Coskun Benlidayi I. The effectiveness and safety of electrotherapy in the management of fibromyalgia. Rheumatol Int. 2020;40(10):1571–80.
Schulze NB, de Melo Salemi M, de Alencar GG, Moreira MC, de Siqueira GR. Efficacy of manual therapy on pain, impact of disease, and quality of life in the treatment of fibromyalgia: a systematic review. Pain Physician. 2020;23(5):461.
Chen X, Lizhi Z, Mu J, Junti LU, Jin XIE, Wang X, et al. Therapeutic effect of duloxetine combined with ozone trigger point injection on fibromyalgia---A retrospective observational study. 2021;